Findings

What do systematic reviews say?

175 questions · 177 findings · 29 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 32 · 18.1%GRADE not reported 13 · 7.3%Very low 49 · 27.7%Low 54 · 30.5%Moderate 25 · 14.1%High 4 · 2.3%

Antipsychotic dose increase vs switching the antipsychotic drug

Service use: 1. Average number of days in hospital per month ‐ by about 24 months · non response in schizophrenia

1 finding from 1 review

Increasing antipsychotic dose versus switching antipsychotic for non response in schizophrenia 2018 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Antipsychotic dose increase vs switching the antipsychotic drug

Average change in quality of life/satisfaction · non response in schizophrenia

1 finding from 1 review

Increasing antipsychotic dose versus switching antipsychotic for non response in schizophrenia 2018 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Gastric bypass vs biliopancreatic diversion with duodenal switch (laparoscopic or open)

Anthropometric measurements other than weight loss in kg (BMI reduction measured inkg/m²) · participants with obesity

1 finding from 1 review

Surgery for weight loss in adults 2014 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 107 participants
Moderate

Gastric bypass vs biliopancreatic diversion with duodenal switch (laparoscopic or open)

Health‐related quality of life · participants with obesity

1 finding from 1 review

Surgery for weight loss in adults 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 60 participants
Very low

Gastric bypass vs biliopancreatic diversion with duodenal switch (laparoscopic or open)

Comorbidities: diabetes · participants with obesity

1 finding from 1 review

Surgery for weight loss in adults 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 60 participants
Very low

Gastric bypass vs biliopancreatic diversion with duodenal switch (laparoscopic or open)

All‐cause mortality · participants with obesity

1 finding from 1 review

Surgery for weight loss in adults 2014 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 107 participants
Moderate

Gastric bypass vs biliopancreatic diversion with duodenal switch (laparoscopic or open)

SAEs · participants with obesity

The review found no eligible studies for this question.

1 finding from 1 review

Surgery for weight loss in adults 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Gastric bypass vs biliopancreatic diversion with duodenal switch (laparoscopic or open)

Reoperation rate · participants with obesity

1 finding from 1 review

Surgery for weight loss in adults 2014 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 107 participants
Very low

Pharmacological interventions vs placebo

GABA analogue VAS(0 to 10 cm) · uraemic pruritus

1 finding from 1 review

Interventions for itch in people with advanced chronic kidney disease 2020 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 297 participants
High

Pharmacological interventions vs placebo

Montelukast Duo score (0 to 81) and VAS (0 to 10 cm) · uraemic pruritus

1 finding from 1 review

Interventions for itch in people with advanced chronic kidney disease 2020 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 87 participants
Moderate

Pharmacological interventions vs placebo

Sertraline VAS(0 to 10 cm) · uraemic pruritus

1 finding from 1 review

Interventions for itch in people with advanced chronic kidney disease 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 46 participants
Low

Topical treatments vs placebo

Capsaicin cream VAS and Duo’s score · uraemic pruritus

1 finding from 1 review

Interventions for itch in people with advanced chronic kidney disease 2020 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 112 participants
Moderate

Topical treatments vs placebo

Pramoxine lotion VAS(0 to 10 cm) · uraemic pruritus

1 finding from 1 review

Interventions for itch in people with advanced chronic kidney disease 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 27 participants
Very low

Topical treatments vs placebo

Calcineurin inhibitor VAS(0 to 10 cm) · uraemic pruritus

1 finding from 1 review

Interventions for itch in people with advanced chronic kidney disease 2020 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 80 participants
Very low

Topical treatments vs placebo

Dead Sea lotion 1 to 5 severity score · uraemic pruritus

1 finding from 1 review

Interventions for itch in people with advanced chronic kidney disease 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 41 participants
Very low

Topical treatments vs placebo

Cromolyn cream VAS (0 to 5 cm) · uraemic pruritus

1 finding from 1 review

Interventions for itch in people with advanced chronic kidney disease 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 60 participants
Low

Pharmacological interventions vs placebo

Ondansetron VAS(0 to 10 cm) · uraemic pruritus

1 finding from 1 review

Interventions for itch in people with advanced chronic kidney disease 2020 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 183 participants
High

Topical treatments vs placebo

L‐arginine salve 0 to 3 severity score · uraemic pruritus

1 finding from 1 review

Interventions for itch in people with advanced chronic kidney disease 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 48 participants
Low

Topical treatments vs placebo

Polyunsaturated fatty acids VAS (0 to 10 cm) Duo score · uraemic pruritus

1 finding from 1 review

Interventions for itch in people with advanced chronic kidney disease 2020 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 78 participants
Low

Intervention not reported

Polyunsaturated fatty acids 0 to 5severity score · uraemic pruritus

1 finding from 1 review

Interventions for itch in people with advanced chronic kidney disease 2020 · Cochrane Headline outcomes only
no estimate extracted
1 study · 22 participants
Low